伴心透导管边缘到边缘修复的耐用性:专家概述
Andrea Mariani1, Lukas Stolz2, Ralph Stephan von Bardeleben3
1Department of Interventional Cardiology, Thoraxcenter, Cardiovascular Institute, Erasmus University Medical Center Rotterdam, the Netherlands; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
JACC. Cardiovascular interventions
|March 16, 2026
概括
三年后,友管横管边缘到边缘修复 (M-TEER) 显示出越来越多的失败率,特别是在初级友管吐中. 需要进一步的长期数据才能充分了解M-TEER的耐用性.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- mitrale 吐 (MR) 是一个重大的全球健康挑战.
- 两透管边缘到边缘修复 (M-TEER) 为MR提供了一种经过验证的安全性和有效性的最小侵入性治疗选择.
研究的目的:
- 为了评估M-TEER的长期耐用性.
- 为了确定M-TEER失败的风险因素和治疗策略.
主要方法:
- 一项系统的文献审查确定了33项相关研究.
- 针对MR复发率和再干预率计算了权重平均值.
- 分析包括整体,初级和二级MR子组.
主要成果:
- 3年后M-TEER失效率增加,在5年后复发时达到17%,在5年后重新干预时达到9%.
- 与二次MR相比,初级MR的失败率更高 (5年后为41%)
- 重制M-TEER比手术更安全,但复发率很高 (1年后20-40%).
结论:
- 3年后,M-TEER失败发生率上升,特别是在初级MR中.
- 长期后续研究对于全面了解M-TEER耐用性至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
422
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
422
Mitral Regurgitation III: Medical Management
508
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
508
Mitral Valve Prolapse II: Assessment and Management
982
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
982
Mitral Stenosis II: Clinical features and Diagnostic Tests
387
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
387
Mitral Valve Prolapse I: Introduction
855
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
855
Mitral Stenosis I: Introduction
1.1K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K


